An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms

A Lenka, J Jankovic - Expert Review of Neurotherapeutics, 2024 - Taylor & Francis
Introduction Tourette syndrome (TS) is a childhood-onset neurobehavioral disorder
characterized by tics. Pharmacotherapy is advised for patients whose symptoms affect their …

How to mitigate risk of premature cardiovascular disease among children and adolescents with mental health conditions

L Xu, M Zimmermann, H Forkey, J Griffin… - Current atherosclerosis …, 2022 - Springer
Abstract Purpose of Review The goal of this article is to characterize the myriad of ways that
children with mental health conditions can be at risk for premature cardiovascular disease …

Specific metabolic syndrome components predict cognition and social functioning in people with type 2 diabetes mellitus and severe mental disorders

JV Sánchez‐Ortí, V Balanzá‐Martínez… - Acta Psychiatrica …, 2022 - Wiley Online Library
Objective Obesity and metabolic diseases such as metabolic syndrome (MetS) are more
prevalent in people with type 2 diabetes mellitus (T2DM), major depressive disorder (MDD) …

Co-prescription of aripiprazole on prolactin levels in long-term hospitalized chronic schizophrenic patients with co-morbid type 2 diabetes: a retrospective clinical study

X Liu, X Sun, L Li, K Zeng, Y Li, Y Gao, J Ma - Frontiers in Psychiatry, 2023 - frontiersin.org
Background One of the most frequent side effects of atypical antipsychotics is
hyperprolactinemia (HPRL), and metformin or aripiprazole co-prescription is regarded as an …

Management of psychiatric disorders in patients with endocrine disorders

KK Mishra, N Sawant, S Garg - Indian journal of psychiatry, 2022 - journals.lww.com
The neuropsychiatric symptoms and disorders among endocrine disorders are discussed in
the context of current global and local epidemiological data. Neuropsychiatric symptoms …

[HTML][HTML] Antipsychotic polypharmacy in treatment of schizophrenia; should or should not?

CU Pae - Chonnam medical journal, 2020 - ncbi.nlm.nih.gov
Antipsychotics have been utilized as the standard treatment for schizophrenia regardless of
illness phase where antipsychotic monotherapy (APM) is routinely recommended as the …

Exploring the Association between Schizophrenia and Cardiovascular Diseases: Insights into the Role of Sigma 1 Receptor

J Rafcikova, M Nováková, T Stracina - Physiological Research, 2023 - pmc.ncbi.nlm.nih.gov
Contemporary society is characterized by rapid changes. Various epidemiological, political
and economic crises represent a burden to mental health of nowadays population, which …

Monitoring for the metabolic side effects of second‐generation antipsychotic medications: Psychiatrists' views and practices

B Abdulhaq, LA Dardas, O Sami - Perspectives in Psychiatric …, 2021 - Wiley Online Library
Purpose The aims of this study were to explore (1) the knowledge, attitudes, practices, and
adherence of psychiatrists in Jordan regarding published guidelines for metabolic …

A comparative study on metabolic syndrome in patients with schizophrenia treated using first-generation and second-generation antipsychotics

D Panati, TP Sudhakar, P Swetha… - Archives of Mental …, 2020 - journals.lww.com
Aim and Objectives: The aim is to study the prevalence of metabolic syndrome in patients
with schizophrenia treated with first-generation and second-generation antipsychotics and to …

OPEN ACCESS EDITED BY

M Shalbafan, S Qin, D Ram, GN Porfyri… - Community Series In …, 2024 - books.google.com
OPEN ACCESS EDITED BY Page 137 DOI 10.3389/fpsyt. 2023.1228539 frontiers Frontiers in
Psychiatry TYPE Original Research PUBLISHED 31 October 2023 Check for updates OPEN …